Press Releases Items Per Page 102550 Year None20212020201920182017201620152014 03-30-2021 Daré Bioscience Reports Full Year 2020 Financial Results and Provides a Company Update 03-24-2021 Daré Bioscience Announces Initiation of Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder 03-23-2021 Daré Bioscience to Host Full Year 2020 Financial Results and Company Update Conference Call and Webcast on March 30, 2021 03-22-2021 Daré Bioscience Completes Recruitment in Phase 1 Clinical Trial of DARE-HRT1, a Novel Intravaginal Ring Designed to Deliver Non-Oral, Bio-identical Hormone Therapy for the Treatment of Vasomotor Symptoms & Genitourinary Syndrome Associated with Menopause 03-10-2021 Daré Bioscience to Participate in Upcoming Virtual Conferences 03-08-2021 Daré Bioscience to Participate at the 33rd Annual Roth Conference 03-02-2021 Daré Bioscience to Present at the H.C. Wainwright Global Life Sciences Conference 02-25-2021 Daré Bioscience to Participate in Maxim Group’s Late Stage Innovations in Women’s Health Virtual Event 02-16-2021 Daré Bioscience to Participate at the Women’s Health Innovation Series: Contraception Innovation Summit to be held Virtually on February 23, 2021 02-09-2021 Daré Bioscience to Present at the 2021 BIO CEO & Investor Digital Conference Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 11
03-24-2021 Daré Bioscience Announces Initiation of Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder
03-23-2021 Daré Bioscience to Host Full Year 2020 Financial Results and Company Update Conference Call and Webcast on March 30, 2021
03-22-2021 Daré Bioscience Completes Recruitment in Phase 1 Clinical Trial of DARE-HRT1, a Novel Intravaginal Ring Designed to Deliver Non-Oral, Bio-identical Hormone Therapy for the Treatment of Vasomotor Symptoms & Genitourinary Syndrome Associated with Menopause
02-25-2021 Daré Bioscience to Participate in Maxim Group’s Late Stage Innovations in Women’s Health Virtual Event
02-16-2021 Daré Bioscience to Participate at the Women’s Health Innovation Series: Contraception Innovation Summit to be held Virtually on February 23, 2021
